Endocrine Abstracts

Endocrine disrupting chemical (EDC) exposure contributes to disease and dysfunction, with annual costs >2% GDP in the US and >1% in Europe. Differences in policy explain differences in disease burden and cost. In Europe, general principles for EDCs call for minimization of human exposure, identification as substances of very high concern, and ban on use in pesticides. In the US, screening and testing programs are focused on estrogenic EDCs exclusively, and regulation i...

Since reports published in 2015 and 2016 identified 15 probable exposure-outcome associations due to endocrine-disrupting chemicals (EDCs), new studies in humans has now deepened understanding of their effects on human health. Particularly stronghas emerged for relations between perfluoroalkyl substances and child and adult obesity, impaired glucose tolerance, gestational diabetes, reduced birthweight, reduced semen quality, polycystic ovarian syndrome, endometriosis, and brea...